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Determinants of Adherence to Antiretroviral Treatment 
among HIV Patients in Ethiopia 




This study investigated factors of adherence to Antiretroviral 
Treatment (ART), factors or variables that can discriminate between 
adherent and non-adherent patients on ART were selected. Simple 
structured questionnaire was employed. The study sample consisted of 
145 HIV patients who received ART in the Shashemene General 
Hospital (SGH). Using self report measure of adherence in the two 
weeks of study period, 81% of the patients on ART were adherent 
whereas 19% of the patients were non adherent. The major reasons of 
non-adherence were: forget to take (28.6%), confused on how and 
when to take (17.9%) and feel depressed (14.2%). Using discriminant 
analysis, depression, poor NGO support and HIV serostatus 
disclosure were identified as barriers of adherence while 
transportation problem, strong NGO support, good reception in the 
service area and high CD4 count were identified as facilitators of 
adherence. To improve adherence of patients on ART, it was 
recommend that the current ART program should strive to manage 
depression before and after the initiation of ART and also strong 
linkage between NGOs which are working in care and support 
program must be established.  
Key Words: Antiretroviral, Adherence, Non Adherence, Discriminant 
Analysis  
Introduction 
HIV/AIDS is an epidemic that affects every part of the globe. 
According to the latest figures, it is estimated that 39.5 million people 
are living with HIV. There were 4.3 million new infections in 2006 
with 2.8 million (65%) of these occurring in Sub-Saharan Africa. 
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(UNAIDS/WHO AIDS epidemic update: December 2006). One of the 
countries hit by HIV/AIDS epidemic in this region is Ethiopia. Based 
on the official figures, 1.3 million people are living with the virus, 
744,100 are orphaned due to AIDS, and 277,800 are in need of 
antiretroviral treatment (ART) in 2005.  Antiretroviral treatment 
(ART) refers to treatment of HIV infection using combination of 
antiretroviral drugs. The introduction of highly active antiretroviral 
therapy (HAART) in 1996 was a turning point for millions of people 
who are living with HIV/AIDS. Although it cannot cure HIV/AIDS, 
antiretroviral (ARV) has dramatically reduced mortality and 
morbidity, prolonged lives, and improved the quality of life of many 
people living with HIV/AIDS in third world countries. 
Notwithstanding these benefits, patients often default in adhering to 
treatment prescription for the following reasons: pill burden, food and 
fluid restriction, temporal side effects such as nausea, vomiting, 
diarrhea and fatigue; and long lasting side effects such as neuropathy, 
lipoatrophy/lipodstrophy, and metabolic disfunction. The treatment 
has to be taken regularly for the rest of the patient’s life with 
maximum adherence (95% and above) in order to obtain the full 
benefit of the treatment. Adherence below 95% is associated with a 
poor viral load or low CD4 count and response, and with faster 
disease progression (Petreson, 2000). Level of adherence below this 
threshold value is referred to as non adherence. Unfortunately, non 
adherence to treatment is common in patients receiving ART 
treatment.  
After the introduction of the free ART program in Ethiopia in 2005, 
non adherence to medication has become a major problem. The paper 
is therefore concerned with investigating the general characteristics of 
adherence and non adherence patients in Shashemene General 
Hospital, Shashemene, Oromia regional state, Ethiopia. In addition, 
the paper is to develop a statistical model that can discriminate the 
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The Data 
A combination of survey data and transcription from hospital records 
were employed in this study. The latter was used to retrieve data on 
type of regimen, disease stage, CD4 count and duration of therapy. 
The hospital’s ART register was the sole sampling frame because 
ART register is exhaustive, non-repetitive, and traceable list of 
patients on ART. The data covers all HIV/AIDS patients attending 
ART medication program in Shashemene General Hospital who came 
to the hospital for their regular drug refill and some of them for 
medical follow up during the month of May (May 1 to May 30, 2007). 
A structured questionnaire was designed and administered to gather 
information on demographic, social support, treatment characteristics, 
patient characteristic and service provision variables.  
Adherence was also measured using the self report adherence measure 
included in the questionnaire. Medical records were inspected in order 
to collect additional clinical information about the patient. Adherence 
was measured over two days, four days, one week and two weeks 
recall of medication intake. The level of adherence required for 
effective HIV therapy is high. Levels below 95% are consistently 
associated with a poor viral load or CD4 response, and with faster 
disease progression (Patterson, 2000). Therefore, a patient is 
considered in this study non adherent if he missed at least one dose 
from his daily medication and missed dose timing (Liu H et al., 2006) 
in two hours delay.  
Before selecting the study sample from the sampling frame, those who 
started the medication in Shashemene General Hospital and those who 
had been transferred from other facilities were given sequential order 
number. A simple random sampling procedure was then applied on 
this list. During the sampling process the hospital’s appointment 
record logbook was also used in order to select the patients who were 
going to come on that data collection day. During the random 
sampling process patients who did not come at the time of the study 
were substituted by the next random number. The patients who were 
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selected by simple random sampling procedure were contacted during 
their visit to the hospital. The observation (Yi) were follows: 
        iY = 1, if the patient is non adherent                                                                           
         =  0,  if the patient is adherent                          














= P                                                                                                                                                 
where P is proportion of non adherent patients and A denote the total 
number of non adherent patients. Using the defaulter rate as an 
estimator of non - adherence rate of Shashemene General Hospital it 
was estimated P to be 9.1%, that is p=0.091. Assume that the 
proportion estimate, p, is normally distributed with absolute margin of 
error d = p-P, then sample size n can be calculated by  
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Where Q = 1-P and Z is the upper bound of two tailed ( α−1 ) 100% 
Confidence interval of standard normal distribution. In practice the 
population parameters P must be estimated while the other factors Z 
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and d usually is set by the investigator. Since population parameter (P) 
is unknown, calculate  0n  by using the estimate of the non adherence. 
That is, p=0.091, Z= 1.96 for 95% confidence interval estimation and 
d to be 0.04, then 
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To calculate n, the total sample size of the study.  The total population 















     = 145.36 145≅  patients (26.9% of N) 
Therefore, a total sample size of 145 patients representing 26.9 % of 
the population was selected.  
Sample Profile and Characteristics:  
Demographic and Socio-Economic Variables  
The study sample was comprised of women (61.9%) and men (38.8%). 
The majority of the participants (48.1%),were either separated or 
widowed, and the rest are still married (42.9%) or never married 
(19%).The participants’ ethnicity comprises the major ethnic groups in 
the country, Oromo (34.4%), Amhara (36.7%), South nations and 
nationalities people (or SNNP) (22.4%) ,and Tigray(6.1%) . As regard 
religious affiliation: Orthodox (54.4%), Protestant (29.3%) and Muslim 
(16.3%). The majority of the respondents were unemployed (75.5%). 
Approximately 89% of the participants reported their monthly income 
as: no income (32%), below 100 birr (57.1%).  Some of the respondents 
who reported below 100 birr said they do not have income but they 
were using informal income earning mechanisms like baking traditional 
“ambasha” and selling. As for education the majority of the respondents 
(72.8%) were either elementary or high school drop outs and 21.1% 
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reported either no education (illiterate) or basic education. More than 
one half of the respondents (56.5%) live in a rented house. The rest 
32% owned a house, 9.5% were homeless (that is, they were living with 
their family and friends) and 2% live in NGO shelter.   
   
Treatment Characteristics  
The health status of the respondents at the time of the study was 
assessed using treatment characteristic variables such as disease stage, 
CD4 count and duration of the Therapy. Almost one half  of the 
respondents were on WHO stage III (47.6%) followed by WHO stage II 
(27.9%) , WHO stage VI (13.6%), WHO stage I(9.5%) and only two 
respondents reported not having  disease stage. Above one third of the 
respondents (34%) reported from 101 to 200 CD4 cell count, from 201 
to 300 CD4 cell count (25.9%), above 300 CD4 cell count (23.1%) and 
less than 100 CD4 cell count(17%). More than one third of the 
respondents reported from six to twelve months of duration of therapy 
(42.9%) and the rest; from two to six months (28.6%), from twelve two 
thirty six months (25.9%) and less than two months (2.7%). 
Patient characteristics 
The health status of the respondents can also be described using the 
depression status of the respondent. According to the scaling mechanism 
– five point Likert scale, the bottom two item scales correspond to 
having depression and the rest not having depression in the study period. 
Therefore, 24.5% reported having depression and the rest do not have 
depression in the study period.  
Regimen complexity  
The type of regimen and the side effect encounter due to this regimen 
which shows drug complexity, in many literatures is a predictive of 
adherence to treatment. All except one of the respondents were on first 
line regimen, twice daily intake and three or two doses per intake. This 
shows no problem with pill burden or food or fluid restriction. But one 
of the respondents reported that she is taking five doses. More than one 
half of the respondents (59.2%) were on 1a30/40(D4T/3TC/NVP), about 
quarter of the respondents were on 1b30/40 (D4T/3TC/EFV),1c (AZT/ 
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3TC/NVP) (8.2%), and 1d (AZT/3TC/EFV) (6.8%).  Almost half of the 
respondents reported no side effect (46.3%). Among those who had 
encountered, 13.6% reported head ache, 12.9% reported fatigue, 7.5% 
had nausea and vomiting and the rest other side effects. 
Disclosure Status, ART Knowledge, and Service Provision and 
Accessibility 
Disclosure status of the respondent can be described using two 
variables such as disclosure to family (spouse, children, mother, father, 
and relatives) and disclosure to community (neighbors, ”Edir” and  
public gathering). Majority (79.6%) of the respondents have disclosed 
their HIV status to spouse, children, mother, father, or relatives. 69.7% 
have disclosed to their community. More than half of the respondents 
reported that confidentiality of the ART service is very good; while the 
rest fear that their status has been known as they come to the hospital. 
64.7% of the respondents reported that service hour delay has been a 
problem and the rest said there is no problem with service hour. 
Majority (96.6%) of the respondents reported sympathetic and good 
reception service provision. That is, the sum of the lowest three ranks in 
the likert scale. 83.0% reported that transportation to the hospital is a 
big problem as the hospital is 12km from Shashemene town. 
Adherence to ART  
Some of the respondents (2%) have totally discontinued the medication 
in the study period. 17% had missed at least one dose of medication and 
dosage timing. Majority of the respondents (54.4%) reported they had 
missed medication but not in the study period. 25.5% of the respondents 
reported they had not missed starting from the beginning of the ART 
therapy. Non adherent respondents claimed that they didn’t understand 
when and how to take medication during their first month of start of 
medication. The mean adherence rate of the Shashemene General 
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Discriminant Analysis 
Discrimination and classification are multivariate techniques concerned 
with separating distinct sets of objects or observations and allocating 
new objects (observations) to previously defined groups. There are two 
goals of discrimination and classification, the first one is to describe 
graphically or algebraically the deferential features of 
objects(observations) from several known collections (populations).The 
second goal is to sort objects (observations) into two or more labeled 
classes, that is, deriving a rule that can be used to optimally assign new 
objects to the labeled classes. 
In order to differentiate between the barriers of adherence and 
facilitators of adherence, data analysis was made for adherent and non 
adherent patients separately. The data was divided into two: those who 
did not adhere to the treatment in the past two weeks prior to the 
assessment and those of who adhere to the treatment. The variables 
which were identified as the loaded variables on HIV serostatus status 
disclosure, home based care and psychological well being in the factor 
analysis were used. Socio demographic variables were analyzed but 
were not significant and were automatically excluded by the SPSS 
stepwise discriminant analysis. The cost function of the SPSS default 
value was used in the analysis.  
Probably the most common application of discriminant function analysis 
is to include many measures in the study, in order to determine the ones 
that discriminate between groups. A "model" on how best to predict 
which group a case belongswas meant to be developed. In stepwise 
discriminant function analysis, a model of discrimination is built step-
by-step. Specifically, at each step all variables are reviewed and 
evaluated to determine which one will contribute most to the 
discrimination between groups. That variable will then be included in 
the model, and the process starts again.  
The stepwise procedure is "guided" by the respective F to enter and F to 
remove values. The F value for a variable indicates its statistical 
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significance in the discrimination between groups, that is, it is a measure 
of the extent to which a variable makes a unique contribution to the 
prediction of group membership. 
Case 1: Adherent Patients  
Prior to data analysis, it was assumed that good service provision, strong 
social support, HIV serostatus disclosure and high CD4 count, no 
transportation problem and good NGO support were facilitators of 
adherence. But after the data analysis it was found that the facilitators of 
adherence included: good reception, strong NGO support, high CD4 
count and free transportation mechanism. The model that significantly 
discriminates among groups of adherent patients is derived as: 
4321 538.0244.0796.0449.0 XXXXY +++−=  
Where Y denote adherent group, X1 is transportation problem, X2      is 
reception, X3   is CD4 count and X4   is NGO support.  
Fisher’s linear discriminant function was used for each of the three 
groups of adherent patients. There are three classification models for 
each group. The classification power of the studies analysis was 
investigated using the classification matrix which shows 66.4% of the 
original group cases classified correctly. Let S1 be those adherent 
patients who has been considered to adhere the treatment “Some of the 
time”. Let S2 be those who had been considered to adhere to the 
treatment “Most of the time”. And finally let S3 be those who had been 
considered to adhere to the treatment “All of the time”. Then following 
the above argument the Fisher’s linear discriminant function for each of 
the groups is given by:  
43211 979.1556.2084.538.1233.16 XXXXS ++++−=
43212 082.1099.2627.3002.2655.11 XXXXS ++++−=
43213 087.2076.3207.3406.1904.13 XXXXS ++++−=
These functions can now be used to assign fresh cases to their 
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respective groups.  
Case 2: Non Adherent Patients  
The variables earlier identified as facilitators of adherence were valuable 
information for the analysis of the data on non adherent patients. Prior to 
the data analysis transportation problem, depression, lack of NGO 
support, and poor service quality were assumed to be the crucial barriers 
to adherence. After the data analysis the variables that qualified to be in 
the discriminating model which are equally identified as barriers of 
adherence included: depression, NGO support and HIV serostatus 
disclosure. These variables have significantly discriminated between the 
two groups of non adherent patients and also observed that there was a 
good canonical correlation between the variables and the dependent 
variable. Finally the model that can discriminate significantly between 
the groups of non adherent patients can be given as: 
         321 683.0805.0935.0 XXXY −+=  
Where the dependent variable Y is adherent to treatment and the 
independent variables are: depression, community disclosure and NGO 
support denoted by X1, X2, and X3 respectively.  
The study further classified the non adherent patients using the two 
group Fisher’s linear discriminant function, into two groups of non 
adherent patients. There were two classification models for each group. 
The classification power of the analysis was investigated using the 
classification matrix which showed 89.3% of the original group cases 
classified correctly. Let S1 be those non adherent patients who said they 
had taken the medication “none of the time”. Similarly let S2 be those 
who said “A little of the time”. Then following the above argument 
Fisher’s linear discriminant function for the two groups are:  
3211 022.1275.3669.4054.17 XXXS −++−=
3212 525.0787.1523.2251.7 XXXS +++−=  
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These functions can now be used to assign fresh cases of non 
adherence patients to their respective groups. 
Conclusion 
Adherence to antiretroviral medications is critically important for the 
success of therapy in patients who are on ART. The mean adherence 
rate of a patient in the hospital has been observed to be 84.62%. This 
study also found that 19% of the respondents are non adherent to 
antiretroviral drugs which is an indication of a need to closely monitor 
this problem in the area. The study  have identified a number of socio-
demographic and economic variables which were associated with 
adherence to ART in the univariate analysis such as occupation, income, 
and level of education, depression and service hour. Whereas in the 
discriminant analysis only depression, NGO support, CD4 count, 
transportation problem, reception and community disclosure variables 
predicted satisfactory adherence to treatment. 
To improve adherence of the patients the intervention areas has to focus 
on patient related factors like depression. Psychiatric consultations and 
appropriate treatment should be more systematically offered to socially 
vulnerable patients. Interventions to improve ART adherence should 
address transportation problem, a strong collaboration in terms of 
information exchange with other NGOs, and a frequent CD4 count 
disclosure has to be made for the HIV patients. 
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